Apyx Medical Corp (APYX) Stock Price, Quote & News

Company Profile

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use...

Industry: Medical Devices

Sector: Healthcare

Phone: 727 384 2323

Website: apyxmedical.com

Address:

5115 Ulmerton Road, Clearwater, United States

OfficialStocktwitsUser Jan. 26 at 10:34 AM

$APYX RSI: 65.36, MACD: 0.0760 Vol: 0.22, MA20: 3.69, MA50: 3.83 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

StockScanners Jan. 14 at 2:50 AM

$APYX reached 3.95

0 · Reply

StockScanners Jan. 13 at 4:55 AM

$$APYX keep watch if this holds above 3.80

0 · Reply

OpenOutcrier Jan. 12 at 1:35 PM

$APYX (+6.6% pre) Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results https://ooc.bz/l/89336

0 · Reply

OfficialStocktwitsUser Dec. 26 at 8:39 PM

$APYX RSI: 28.44, MACD: -0.0469 Vol: 0.21, MA20: 3.83, MA50: 3.64 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

SuperGreenToday Dec. 20 at 12:43 AM

$APYX Share Price: $3.50 Contract Selected: Dec 18, 2026 $2.5 Calls Buy Zone: $1.49 – $1.84 Target Zone: $2.41 – $2.94 Potential Upside: 53% ROI Time to Expiration: 363 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

DARKP00L Dec. 16 at 3:41 PM

$APYX 10:19 on Dec. 16 2025 Roth Capital Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $6 #tradeideas

0 · Reply

JarvisFlow Dec. 16 at 3:19 PM

Roth Capital updates rating for Apyx Medical ( $APYX ) to Buy, target set at 6.

0 · Reply

OpenOutcrier Nov. 18 at 2:16 PM

$APYX (-13.6% pre) Apyx Medical prices $10 million stock offering at $3.62 per share https://ooc.bz/l/84958

0 · Reply

jarias115 Nov. 17 at 9:15 PM

$APYX public offering… sorry guys

0 · Reply

Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results

Dec 3, 2025, 8:00 AM EST - 7 weeks ago

Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea

Nov 18, 2025, 7:30 AM EST - 2 months ago

Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock

Nov 17, 2025, 4:05 PM EST - 2 months ago

Apyx Medical Corporation Announces Proposed Public Offering of Common Stock

Nov 6, 2025, 2:36 PM EST - 2 months ago

Apyx Medical Corporation (APYX) Q3 2025 Earnings Call Transcript

Oct 23, 2025, 8:00 AM EDT - 3 months ago

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025

Oct 14, 2025, 6:56 PM EDT - 3 months ago

Apyx Medical Corporation - Special Call

Aug 8, 2025, 1:52 PM EDT - 6 months ago

Apyx Medical Corporation (APYX) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:01 PM EDT - 6 months ago

Apyx Medical Corporation Reports Second Quarter 2025 Financial Results

Jul 30, 2025, 4:20 PM EDT - 6 months ago

Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference

May 30, 2025, 9:00 AM EDT - 8 months ago

Renuvion® Brings Real Transformations to the Runway at Miami Swim Week

May 13, 2025, 8:00 AM EDT - 9 months ago

Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™

May 11, 2025, 6:34 AM EDT - 9 months ago

Apyx Medical Corporation (APYX) Q1 2025 Earnings Call Transcript

May 1, 2025, 9:00 AM EDT - 9 months ago

Renuvion Introduces Television Star Dolores Catania as Chief of Confidence

Apr 29, 2025, 8:00 AM EDT - 9 months ago

Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures

Apr 24, 2025, 8:45 AM EDT - 9 months ago

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

Mar 25, 2025, 9:00 AM EDT - 11 months ago

Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Mar 13, 2025, 11:48 AM EDT - 11 months ago

Apyx Medical Corporation (APYX) Q4 2024 Earnings Call Transcript

Jan 6, 2025, 8:00 AM EST - 1 year ago

Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System™

Nov 12, 2024, 4:05 PM EST - 1 year ago

Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference

Nov 8, 2024, 1:39 PM EST - 1 year ago

Apyx Medical Corporation (APYX) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 7:05 AM EST - 1 year ago

Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering

Nov 8, 2024, 7:00 AM EST - 1 year ago

Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook

Oct 25, 2024, 8:00 AM EDT - 1 year ago

Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024

Aug 13, 2024, 8:10 AM EDT - 1 year ago

Renuvion Named #1 Trusted Body Contouring Technology by Doctors*

Aug 11, 2024, 6:39 AM EDT - 1 year ago

Apyx Medical Corporation (APYX) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:10 PM EDT - 1 year ago

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures

Aug 8, 2024, 4:05 PM EDT - 1 year ago

Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook

Jul 25, 2024, 7:30 AM EDT - 1 year ago

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024

Jun 26, 2024, 7:30 AM EDT - 1 year ago

Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health

May 11, 2024, 6:33 PM EDT - 1 year ago

Apyx Medical Corporation (APYX) Q1 2024 Earnings Call Transcript

May 9, 2024, 7:05 AM EDT - 1 year ago

Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook

May 9, 2024, 7:00 AM EDT - 1 year ago

Apyx Medical Corporation Announces Board Leadership Transition

Apr 25, 2024, 7:30 AM EDT - 1 year ago

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

Apr 11, 2024, 7:30 AM EDT - 1 year ago

Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users' Summit

Mar 21, 2024, 10:12 AM EDT - 2 years ago

Apyx Medical Corporation (APYX) Q4 2023 Earnings Call Transcript

Mar 21, 2024, 7:00 AM EDT - 2 years ago

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook

Mar 4, 2024, 7:30 AM EST - 2 years ago

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024

Feb 21, 2024, 7:30 AM EST - 2 years ago

Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting

Jan 22, 2024, 7:30 AM EST - 2 years ago

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body

Jan 8, 2024, 7:00 AM EST - 2 years ago

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results

Nov 28, 2023, 8:30 AM EST - 2 years ago

Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer

Nov 9, 2023, 11:30 AM EST - 2 years ago

Apyx Medical Corporation (APYX) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 7:01 AM EST - 2 years ago

Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors

Nov 9, 2023, 7:00 AM EST - 2 years ago

Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook

Nov 7, 2023, 7:30 AM EST - 2 years ago

Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November

Oct 2, 2023, 7:30 AM EDT - 2 years ago

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023

Aug 12, 2023, 12:09 PM EDT - 2 years ago

Apyx Medical Corporation (APYX) Q2 2023 Earnings Call Transcript

Aug 10, 2023, 4:05 PM EDT - 2 years ago

Apyx Medical Corporation Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Outlook

Jun 29, 2023, 4:05 PM EDT - 2 years ago

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2023 Financial Results on August 10, 2023

OfficialStocktwitsUser Jan. 26 at 10:34 AM

0 · Reply

StockScanners Jan. 14 at 2:50 AM

$APYX reached 3.95

0 · Reply

StockScanners Jan. 13 at 4:55 AM

$$APYX keep watch if this holds above 3.80

0 · Reply

OpenOutcrier Jan. 12 at 1:35 PM

$APYX (+6.6% pre) Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results https://ooc.bz/l/89336

0 · Reply

OfficialStocktwitsUser Dec. 26 at 8:39 PM

0 · Reply

SuperGreenToday Dec. 20 at 12:43 AM

0 · Reply

DARKP00L Dec. 16 at 3:41 PM

$APYX 10:19 on Dec. 16 2025 Roth Capital Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $6 #tradeideas

0 · Reply

JarvisFlow Dec. 16 at 3:19 PM

Roth Capital updates rating for Apyx Medical ( $APYX ) to Buy, target set at 6.

0 · Reply

OpenOutcrier Nov. 18 at 2:16 PM

$APYX (-13.6% pre) Apyx Medical prices $10 million stock offering at $3.62 per share https://ooc.bz/l/84958

0 · Reply

jarias115 Nov. 17 at 9:15 PM

$APYX public offering… sorry guys

0 · Reply

StockScanners Nov. 13 at 3:26 AM

$APYX reached 4.44

0 · Reply

JarvisFlow Nov. 12 at 2:13 PM

Citizens has updated their rating for Apyx Medical ( $APYX ) to Market Outperform with a price target of 8.

0 · Reply

BioTechHealthX Nov. 9 at 7:40 AM

$APYX Apyx Medical reports 12.1% revenue growth and 64.4% gross margin, fueled by AYON sales and record U.S. adoption. Check this out! https://biotechhealthx.com/biotech-news/apyx-medical-apyx-surges-15-after-record-q3-revenue-of-12-9m/

0 · Reply

cache1b Nov. 9 at 12:05 AM

$APYX Pinging on scanner...

0 · Reply

cache1b Nov. 8 at 11:50 PM

$APYX @LefDeppard in

3 · Reply

StockScanners Nov. 8 at 4:48 AM

$APYX keep watch if this holds above 3.50

0 · Reply

Stwts_scks Nov. 7 at 8:48 PM

$APYX Nice earnings... Next stop solid 4s then 5.

0 · Reply

Doozio Oct. 14 at 7:04 PM

$APYX wen? It’s Tuesday.

0 · Reply

LukaMagic77 Oct. 14 at 5:02 PM

$APYX 🤩

0 · Reply

Doozio Oct. 10 at 1:21 AM

$APYX the huckleberries shud meet their “potential” during 🐒🍌🧠⏰♾️

0 · Reply

CalculatedSwing Oct. 9 at 2:37 PM

$VTAK 🚀 $VTAK just hit my radar hard—grabbed 20K shares at $2.91 on the dip, and here's why new investors should pile in NOW! UK MHRA approval for LockeT system already sparked 70% pops, with EU/CE mark & Oct 10 special meeting unlocking global scale. Q3 earnings Nov 12 could explode rev 200%+ YoY on EP mapping traction—tiny $3.8M cap = 10x moonshot potential in $10B cardiac space. Who's loading up? #MedTech #Biotech Tag squad: $BJDX $SSKN $IBRX $APYX

1 · Reply

ja1234567 Oct. 6 at 11:24 PM

$APYX ok What’s going on. massive gains 2 days in a row. Someone must know their numbers

0 · Reply

Market Cap	151.82M
Revenue (ttm)	48.10M
Net Income (ttm)	-23.46M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-48.77%
Debt to Equity Ratio	5.69

Volume	81,700
Avg Vol	118,360
Day's Range	N/A - N/A
Shares Out	38.24M
Stochastic %K	36%
Beta	1.53
Analysts	Strong Sell
Price Target	$6.00